Evaxion Biotech A/S (EVAX) News Today $2.68 -0.16 (-5.63%) (As of 10/9/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trialsOctober 9 at 3:19 PM | markets.businessinsider.comStrong validation of Evaxion's AI-Immunology™ platform in multiple clinical trialsOctober 9 at 8:00 AM | globenewswire.comClinical Evidence Supports Advancement of Evaxion's AI-Immunology PlatformOctober 5, 2024 | msn.comEvaxion Biotech Charts Future with Innovative Immune TherapiesOctober 4, 2024 | finance.yahoo.comEvaxion Biotech: Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology platformOctober 3, 2024 | finanznachrichten.deRecent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platformOctober 3, 2024 | globenewswire.comEvaxion Biotech A/S (NASDAQ:EVAX) and Regen BioPharma (OTCMKTS:RGBP) Financial AnalysisOctober 3, 2024 | americanbankingnews.comEvaxion Biotech (EVAX) Gets a Buy from Lake StreetSeptember 27, 2024 | markets.businessinsider.comEvaxion significantly expands vaccine development collaboration with MSDSeptember 26, 2024 | globenewswire.comEvaxion Biotech enhances AI vaccine discovery platformSeptember 21, 2024 | uk.investing.comEvaxion Biotech Unveils Enhanced AI Platform for Improved Vaccine DevelopmentSeptember 21, 2024 | msn.comLife Sciences Virtual Investor Forum Presentations Now Available for Online ViewingSeptember 20, 2024 | finance.yahoo.comBuy Rating for Evaxion Biotech Supported by Strong Clinical Results and PIONEER Platform’s PotentialSeptember 20, 2024 | markets.businessinsider.comEvaxion launches improved AI-Immunology™ platform for vaccine antigen predictionSeptember 19, 2024 | globenewswire.comEvaxion Biotech Reports Positive One-Year Results for AI-Designed Cancer VaccineSeptember 18, 2024 | msn.comEvaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01September 16, 2024 | markets.businessinsider.comEvaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01September 9, 2024 | markets.businessinsider.comEvaxion Biotech: Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2September 9, 2024 | finanznachrichten.deEvaxion Biotech: Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01September 9, 2024 | finanznachrichten.deEvaxion Biotech: Clinical Phase 2 Data Supports Clinical Profile Of EVX-01September 9, 2024 | markets.businessinsider.comEvaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2September 9, 2024 | globenewswire.comEvaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near?August 30, 2024 | finance.yahoo.comBuy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical TrialsAugust 16, 2024 | markets.businessinsider.comEarnings To Watch: Home Depot (HD) Reports Q2 Results TomorrowAugust 12, 2024 | uk.finance.yahoo.comEvaxion Biotech: Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14August 12, 2024 | finanznachrichten.deEvaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14August 12, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday TradingAugust 8, 2024 | msn.comEvaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in SeptemberAugust 8, 2024 | globenewswire.comBuy Rating for Evaxion Biotech: EVX-01’s Personalized Cancer Vaccine Shows Promising Efficacy and SafetyAugust 1, 2024 | markets.businessinsider.comBiotech company's CEO pleads guilty in Mississippi welfare fraud caseJuly 26, 2024 | msn.comEQS-Adhoc: BB Biotech AG publishes its interim report and announces a new head of its investment management teamJuly 26, 2024 | markets.businessinsider.comEvaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology ConferenceJuly 16, 2024 | globenewswire.comEvaxion Reinforces Milestone Timeline and Provides Shareholder UpdateJuly 3, 2024 | globenewswire.comEvaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification MethodJune 26, 2024 | globenewswire.comEvaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical JournalJune 17, 2024 | globenewswire.comEvaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024June 3, 2024 | globenewswire.comEvaxion Biotech: Evaxion Announces Business Update and First Quarter 2024 Financial ResultsMay 28, 2024 | finanznachrichten.deEvaxion Announces Business Update and First Quarter 2024 Financial ResultsMay 28, 2024 | globenewswire.comEvaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination TreatmentMay 24, 2024 | finance.yahoo.comEvaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024May 23, 2024 | globenewswire.comEvaxion Biotech: Evaxion Receives Nasdaq NotificationMay 11, 2024 | finanznachrichten.deEvaxion Receives Nasdaq NotificationMay 10, 2024 | globenewswire.comEvaxion Biotech A (EVAX) Price Target Decreased by 13.62% to 11.99April 17, 2024 | msn.comEvaxion Biotech: Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01April 17, 2024 | finanznachrichten.deEvaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01April 17, 2024 | finance.yahoo.comEvaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01April 17, 2024 | globenewswire.comQ4 2023 Evaxion Biotech A/S Earnings Call (Danish)April 3, 2024 | finance.yahoo.comEvaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call TranscriptApril 3, 2024 | finance.yahoo.comADRs End Lower; Meta Data Slides 22%April 2, 2024 | marketwatch.comEvaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus InfectionApril 2, 2024 | globenewswire.com Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Bigger Than Nvidia? (Ad)Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about. Go here now for this breaking story. EVAX Media Mentions By Week EVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVAX News Sentiment▼0.600.51▲Average Medical News Sentiment EVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVAX Articles This Week▼72▲EVAX Articles Average Week Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LianBio News Today BriaCell Therapeutics News Today PHAXIAM Therapeutics News Today Inhibikase Therapeutics News Today Windtree Therapeutics News Today Kaleido Biosciences News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVAX) was last updated on 10/9/2024 by MarketBeat.com Staff From Our PartnersBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
